Skip to main content
Clinical Trials/CTRI/2024/02/062213
CTRI/2024/02/062213
Recruiting
Phase 4

A clinical comparitive study to find the efficacy of Formica rufa 6CH and 30CH potencies in the treatment of gout - NI

VINAYAKA MISSION HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITA0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: M109- Gout, unspecified
Sponsor
VINAYAKA MISSION HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITA
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
VINAYAKA MISSION HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITA

Eligibility Criteria

Inclusion Criteria

  • clinically diagnosed gout patients

Exclusion Criteria

  • gouty complications like joint deformity and bone loss
  • Pregnant females and lactating mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials